5.3 Renal & Electrolyte Management in ICU

Acute Kidney Injury (AKI) in the ICU

Acute Kidney Injury (AKI) is characterized by a rapid decline in glomerular filtration rate, leading to the accumulation of nitrogenous waste products and dysregulation of fluid, electrolyte, and acid-base homeostasis.

Diagnostics and Classification

AKI is clinically defined using the KDIGO criteria, which rely on two primary biomarkers:

• Serum Creatinine (SCr): An increase of $\ge 0.3$ mg/dL within 48 hours, or a $\ge 1.5$-fold increase from baseline.
• Urine Output: Oliguria is defined as urine output < 0.5 mL/kg/hour for 6 consecutive hours. Anuria is the complete absence of urine output (< 50 mL/day).

Pulmonary Consequences of AKI

Renal failure directly impacts the respiratory system:

1. Fluid Overload: Reduced glomerular filtration leads to sodium and water retention. Fluid accumulates in the pulmonary interstitium and alveoli, causing cardiogenic/hydrostatic pulmonary edema. This decreases lung compliance, increases shunt fraction, and worsens hypoxemia, requiring higher PEEP and $FiO_2$.
2. Metabolic Acidosis: The kidneys fail to excrete fixed metabolic acids (e.g., phosphoric and sulfuric acids) and fail to reabsorb bicarbonate. The body compensates by stimulating the central chemoreceptors, leading to deep, rapid hyperventilation (Kussmaul breathing) to blow off $CO_2$. In a patient with marginal respiratory reserve, this compensatory work of breathing can lead to respiratory muscle fatigue, necessitating mechanical ventilation.

---

Electrolyte Derangements and Respiratory Function

Electrolytes are essential for maintaining the membrane potentials of neuromuscular and cardiac tissues. Derangements can lead to respiratory failure and weaning difficulties.

Potassium ($K^+$)

• Normal Range: 3.5 to 5.0 mEq/L.
• Hyperkalemia ($> 5.0$ mEq/L): Commonly caused by renal failure. It alters the cardiac resting membrane potential.
  • ECG Changes: Tall, peaked T-waves, prolonged PR interval, QRS widening, loss of P-waves, and a sinusoidal pattern leading to ventricular fibrillation.
  • Treatment Protocol:
    1. Calcium Gluconate (1 to 2 g IV): Stabilizes the cardiac membrane to prevent arrhythmias (does not lower potassium).
    2. Insulin (10 units IV) + Dextrose 50% (50 mL): Shifts potassium into the intracellular space by stimulating the sodium-potassium ATPase pump.
    3. Nebulized Albuterol (10 to 20 mg): High-dose beta-2 agonist therapy drives potassium into cells. This dose is 4 to 8 times the standard bronchodilator dose.
• Hypokalemia ($< 3.5$ mEq/L): Often caused by aggressive loop diuretic therapy (e.g., furosemide). It causes muscle weakness, diaphragmatic fatigue, flattened T-waves, and prominent U-waves on ECG, predicting failure to wean from the ventilator.

Phosphorus ($PO_4^{3-}$)

• Normal Range: 2.5 to 4.5 mg/dL.
• Hypophosphatemia ($< 2.5$ mg/dL): This is a critical weaning concept. Phosphorus is required for the synthesis of adenosine triphosphate (ATP) and 2,3-diphosphoglycerate (2,3-DPG). Severe hypophosphatemia ($< 1.5$ mg/dL) depletes cellular energy stores, causing profound skeletal muscle weakness. This leads to diaphragmatic fatigue and failure of Spontaneous Breathing Trials (SBTs). The clinician must ensure phosphorus is repleted before attempting to wean the patient.

Calcium ($Ca^{2+}$)

• Normal Range: 8.5 to 10.5 mg/dL (ionized: 4.5 to 5.6 mg/dL).
• Hypocalcemia: Causes neuromuscular excitability, tetany, Chvostek's sign (facial twitching when the facial nerve is tapped), and a prolonged QT interval.

---

Acid-Base Management and Bicarbonate Therapy

In patients with severe metabolic acidosis due to renal failure, the administration of sodium bicarbonate ($NaHCO_3$) is controversial.

• The Intracellular Acidosis Paradox: Bicarbonate combines with hydrogen ions to form carbonic acid, which dissociates into water and carbon dioxide: $NaHCO_3 + H^+ \\rightleftharpoons H_2CO_3 \\rightleftharpoons H_2O + CO_2$ While serum bicarbonate and pH may rise, the newly generated $CO_2$ is highly lipid-soluble and diffuses rapidly across cell membranes into the intracellular space (including myocardial cells and the brain). Inside the cells, $CO_2$ recombines with water to form carbonic acid, worsening intracellular acidosis and depressing myocardial contractility.
• Ventilator Adjustments: If bicarbonate is administered, the patient must have adequate alveolar ventilation to blow off the excess $CO_2$. The RT must temporarily increase the ventilator's minute ventilation (via rate or volume) to prevent acute respiratory acidosis.

---

Continuous Renal Replacement Therapy (CRRT)

For hemodynamically unstable patients with AKI, CRRT provides slow, continuous fluid and solute clearance over 24 hours, avoiding the hypotension associated with intermittent hemodialysis.

• Regional Citrate Anticoagulation (RCA): To prevent blood from clotting in the extracorporeal filter, citrate is infused into the circuit. Citrate chelates (binds) calcium, which is a necessary cofactor in the clotting cascade, preventing thrombus formation. Before the blood is returned to the patient, calcium is infused to restore systemic coagulation.
  • Complication: If citrate metabolism is impaired (e.g., in liver failure), the patient can develop citrate toxicity, presenting as severe hypocalcemia and metabolic alkalosis.